Abstract
In this issue of Blood, Dubovsky et al show that ibrutinib inhibits interleukin-2 (IL-2) inducible kinase (ITK) and thereby modulates T-cell signaling and function. © 2013 by The American Society of Hematology.
Cite
CITATION STYLE
APA
Ansell, S. M. (2013, October 10). Two targets for the price of one. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2013-08-518548
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free